Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled furosemide for dyspnoea relief in advanced heart failure
ISRCTN14593637Phase 2Completed
- Sponsor
- University of Oxford
- Start
- Apr 2018
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of furosemide in heart failure (HF) (2 arms), sponsored by University of Oxford. Primary endpoint: Air hunger during experimentally induced breathlessness. Started Apr 2018; status: completed.
02
Drugs
furosemide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on ISRCTN14593637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN14593637.